Showing results (531-540 of 1,751) with videos related to
Sort By:
Pageof 176
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 31, 2019
Variation of Programmed Death Ligand 1 Expression After Platinum-based Neoadjuvant Chemotherapy in Lung CancerLei Guo, Peng Song, Xuemin Xue, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 9, 2019
Blood Immune Cell Biomarkers in Patient With Lung Cancer Undergoing Treatment With Checkpoint BlockadeMiriam Möller, Steffi Turzer, Wolfgang Schütte, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2019
Functionally Defective T Cells After Chemotherapy of B-Cell Malignancies Can Be Activated by the Tetravalent Bispecific CD19/CD3 Antibody AFM11Johannes Duell, Dragana S Lukic, Margarete Karg, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 25, 2022
PD-1 Inhibitor Plus Chemotherapy Versus Chemotherapy as First-line Treatment for Advanced Esophageal Cancer: A Systematic Review and Meta-AnalysisYao Lu, Mengli Xu, Lulu Guan, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 11, 2022
Modified Protocol of Nivolumab in Relapsed/Refractory Hodgkin Lymphoma: A Brief Communication of Real World DataNeha Pathak, Raja Pramanik, Sameer Bakhshi, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 1, 2021
Treatment of Platinum Nonresponsive Metastatic Malignant Peritoneal Mesothelioma With Combination ChemoimmunotherapyMichael B Foote, Jinru Shia, Marjorie G Zauderer, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 1999
THF-gamma 2-mediated reduction of pulmonary metastases and augmentation of immunocompetence in C57BL/6 mice bearing B16-melanomaR Ophir, G Moalem, M Pecht, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 23, 2000
Expression of the SART3 tumor-rejection antigen in brain tumors and induction of cytotoxic T lymphocytes by its peptidesK Murayama, T Kobayashi, T Imaizumi, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 23, 2000
Endothelial monocyte-activating polypeptide II, a tumor-derived cytokine that plays an important role in inflammation, apoptosis, and angiogenesisA C Berger, G Tang, H R Alexander, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 23, 2000
Effects of tumor necrosis factor-alpha on the in vitro maturation of tumor-reactive effector T cellsK Tanigawa, R A Craig, L M Stoolman, et al.Pageof 176